As President of Bayer Group for Greater China (2014 to 2019), I was responsible for Bayer’s operations in Greater China, Bayer’s third largest market with sales exceeding Euro 3 billion in 2018, approximately 10% of global sales. In this period, my achievements include:
– Leading Bayer’s operations in Greater China during a period of growth across all businesses and overseeing significant portfolio and organizational transformation – Actively supporting multiple initiatives on innovation, digitalization, culture change, people strategy, diversity and inclusion, female leadership, sustainability, corporate social responsibility
– Actively participating in the Boards of Bayer companies in China, global Bayer committees on various topics (digitalization, culture change, people strategy, innovation) as well as external Boards and advisory positions (eg European Chamber of Commerce China Shanghai(EUCCC) Board member, Enactus China Board member, Advisor to Ladies Who Tech supporting women in STEM)
– Driving the establishment of G4A Shanghai, Hong Kong and Taiwan, Bayer’s digital health incubatorsfor external start-ups, in collaboration with HKSTP in Hong Kong and H Spectrum in Taiwan
– Magnolia Award from Shanghai Government (2015)
– Forbes China Top 100 Businesswomen in China List (2017 and 2019)
– International Friendship Award from IESE Barcelona, presented by the Queen of Spain (2018)
Back to Top
|